CombiGene Competitors and Similar CompaniesClear all

CombiGene's competitors and similar companies include Envigo, Beam Therapeutics, Elim Biopharm and Akouos.

	CombiGene CombiGene is a gene therapy company.	Envigo Envigo is a company that provides research models and services.	Beam Therapeutics Beam Therapeutics is a biotechnology company that develops precision genetic medicines making edits to individual base pairs in the genetic code.	Elim Biopharm Elim Biopharmaceuticals is a life science service company for the biotech, pharmaceutical, and medical communities.	Akouos Akouos is a precision genetic medicine company focused on developing gene therapies to treat hearing disorders.
Founding Date	Founding Date 2008	Founding Date 2015	Founding Date 2017	Founding Date 1998	Founding Date 2016
Type	Type Public	Type Subsidiary	Type Public	Type Private	Type Subsidiary
Tags	Tags Healthcare biotech clinical research genetics pharma	Tags Healthcare biotech clinical research drug development genetics pharma	Tags Healthcare biotech clinical research genetics pharma	Tags Healthcare biotech clinical research genetics life sciences pharma	Tags Healthcare biotech clinical research drug development genetics pharma
Locations	Locations Lund, SE HQ	Locations Indianapolis, US HQ Gannat, FR Jerusalem, IL Bresso, IT Desio, IT Udine, IT Horst, NL see more	Locations Boston, US HQ	Locations Hayward, US HQ	Locations Boston, US HQ
Employees	Employees 9	Employees 503	Employees 11229% increase	Employees 215% decrease	Employees 913% decrease
Valuation ($)	Valuation ($) 3.3 m	Valuation ($) N/A	Valuation ($) 1.8 b	Valuation ($) N/A	Valuation ($) N/A
Financial
Revenue (est.)	Revenue (est.) N/A	Revenue (est.) N/A	Revenue (est.) $139.7m (FY, 2025)	Revenue (est.) N/A	Revenue (est.) N/A
Net income	Net income (kr12.4m) (FY, 2025)	Net income N/A	Net income ($80m) (FY, 2025)	Net income N/A	Net income ($86.7m) (FY, 2021)
Funding
Total funding raised	Total funding raised $ 3.9m	Total funding raised N/A	Total funding raised $ 222m	Total funding raised N/A	Total funding raised $ 162.5m